Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Presentation TCT 2024

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

Presenter: Seokhun Yang

October 30, 2024

Presentation TCT 2024

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

Presenter: Chun-Wei Lee

October 29, 2024

Presentation TCT 2024

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

Presenter: Hyun Jin Ahn

October 28, 2024

Presentation TCT 2024

Artificial-Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: The Multi-Center International CONFIRM2 Registry

Presenter: Alexander Van Rosendael

October 28, 2024

Presentation NY Valves 2024

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Presenter: Masaaki Nakase

June 05, 2024

Presentation Controversies and Advances 2023

Anti-inflammatory Drugs to Inhibit Atherosclerosis: Old and New

Presenter: Christie M. Ballantyne

November 30, 2023

Presentation Complex Coronary Cases 2023

CCC2023 Cardiology Board Review 2023: Basic Concepts in Atherosclerosis

Presenter: Pedro R. Moreno

June 14, 2023

Advertisement

High Risk Coronary Atherosclerosis Identified by AI Algorithms and Its Prognostic Timeframe for Predicting Acute Coronary Syndromes

TCT 793: Unraveling the Connection: Central Obesity, Atherosclerosis, and Heart Failure in African Americans: Focusing on the Mediating Role of Atherosclerosis

TCT 1009: Effect of Statin on Different Stages of Coronary Plaque Evolution Defined by Topological Data Analysis of Coronary Atherosclerosis

Artificial-Intelligence Enabled Quantitative CT Assessment of Atherosclerosis and Major Adverse Events: The Multi-Center International CONFIRM2 Registry

Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR

Anti-inflammatory Drugs to Inhibit Atherosclerosis: Old and New

CCC2023 Cardiology Board Review 2023: Basic Concepts in Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content